MalekMohamadSafaMD

PubMed

• Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
  Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, ...> ;Cancer Research Communications. 2023 Jul 1
• 6 citations
  Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
  Tomlins, S., Khazanov, N., Bulen, B., Hovelson, D., Shreve, M., Lamb, L., Matrana, M., Burkard, M., Yang, E., Edenfield, W., Dees, E., Onitilo, A., Thompson, M., Buchs...> ;Communications Medicine. 2023 Feb 7
• 13 citations
  Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
  Scott A. Tomlins, Daniel H. Hovelson, Jennifer Marie Suga, Daniel M. Anderson, Han A. Koh, Elizabeth Claire Dees, Brendan McNulty, Mark E. Burkard, Michael Guarino, Ja...> ;JCO Precision Oncology. 2021 Aug 19
• 47 citations
  Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data.
  Rami S. Komrokji, Najla Al Ali, Muhammad Shaalan Beg, M. M. Safa, Dana E. Rollison, Mohamed A. Kharfan-Dabaja, Celeste M. Bello, Jennifer Cultrera, Lubomir Sokol, Javi...> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Jun 1
• 9 citations
  Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.
  Julianna V. F. Roddy, Suzanne M. Partridge, Michelle L. Rockey, Jane M. Pruemer, Jeff J. Guo, Shaili J. Desai, M. M. Safa> ;American Journal of Clinical Oncology. 2010 Feb 1
• 14 citations
  Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
  Rami S. Komrokji, Gina M. Matacia-Murphy, Najla Al Ali, Muhammad Shaalan Beg, M. M. Safa, Dana E. Rollison, Alan F. List> ;Leukemia Research. 2010 Jan 1
• Does race impact survival in VA patients with gastric cancer?
  Ali S, Navaneethan U, Beg MS, Safa MM> ;J. Clin. Oncol.. 2008-05-20
• Intrahepatic versus extrahepatic cholangiocarcinoma: Is there a difference in survival?
  Ahmed K, Beg MS, Komrokji R, Safa MM> ;J. Clin. Oncol.. 2008-05-20
• Characteristics of proximal versus distal gastric cancer at the VA: Is there a difference?
  Navaneethan U, Beg MS, Komrokji R, Safa MM> ;J. Clin. Oncol.. 2008-05-20
• Has the outcome of cholangiocarcinoma in the United States improved? A review of SEER data.
  Beg MS, Komrokji R, Ahmed K, Safa MM> ;J. Clin. Oncol.. 2008-05-20
• Ampulla of Vater adenocarcinoma in the Veteran's Affairs population.
  Safa MM, Ahmed K, Beg MS> ;J. Clin. Oncol.. 2008-05-20
• 20 citations
  Oxaliplatin-induced immune mediated thrombocytopenia.
  Muhammad Shaalan Beg, Rami S. Komrokji, Kashif Ahmed, M. M. Safa> ;Cancer Chemotherapy and Pharmacology. 2008 Jan 19
• 3 citations
  Diagnosis of peritoneal carcinomatosis by EUS-guided FNA.
  Nathan Schmulewitz, Paramvir Singh, Malek Safa, Toni Robinson-Smith> ;Gastrointestinal Endoscopy. 2007 Oct 1
• 8 citations
  A phase II study of sequential neoadjuvant gemcitabine and paclitaxel, radiation therapy with cisplatin and 5-fluorouracil and surgery in locally advanced esophageal c...
  Andrew M. Lowy, Irfan Firdaus, Debasish Roychowdhury, Kevin P. Redmond, John A. Howington, Jeffrey J. Sussman, M. M. Safa, Syed A. Ahmad, Michael F. Reed, Patricia Ros...> ;American Journal of Clinical Oncology. 2006 Dec 1
• Hodgkin's lymphoma among veterans: Does race matter?
  Komrokji RS, Mekan SF, Safa MM, Nahleh ZA, Pancoast JR, Muhleman AF, Jazieh AR> ;J. Clin. Oncol.. 2006-06-20
• Hodgkin's lymphoma in the elderly veterans: We need to do better.
  Al Sayyed MH, Maken SF, Safa MM, Nahleh ZA, Pancoast JR, Muhleman AF, Jazieh AR, Komrokji RS> ;J. Clin. Oncol.. 2006-06-20
• Improvement of survival in VA patients with gall bladder cancer given chemotherapy.
  Atiq M, Safa MM, Komrokji RS, Jazieh AR, Muhleman AF, Nahleh ZA, Pancoast J> ;J. Clin. Oncol.. 2006-06-20
• Do racial differences predict survival amongst VA patients with colon cancer?
  Safa M, Atiq M, Komrokji R, Nahleh Z, Pancoast J, Muhleman A, Jazieh AR> ;J. Clin. Oncol.. 2006-06-20
• Is hyperglycemia a prognostic factor in pancreatic cancer?
  Mekan SF, Safa MM, Komrokji RS, Nahleh ZA, Jazieh AR> ;J. Clin. Oncol.. 2006-06-20
• 15 citations
  Bilateral synchronous breast cancer and HER-2/neu overexpression.
  M. M. Safa, Elyse E. Lower, Per-Olof Hasselgren, Eric S. Hungness, Paula Gazder, Bernard S. Aron, Elizabeth A. Shaughnessy, Rawia Yassin> ;Breast Cancer Research and Treatment. 2002 Apr 1
• Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
  Groebli, Y., Wutrich, P., Safa, M., Tschantz, P., Callewaert, G., Piguet, D.> ;Panminerva Med. 1999 Jun
• 21 citations
  Adjuvant immunotherapy for melanoma and colorectal cancers.
  Malek M. Safa, Kenneth A. Foon> ;Seminars in Oncology. 2001 Feb 1
• 62 citations
  Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts.
  Eric S. Hungness, M. M. Safa, Elizabeth A. Shaughnessy, Bernard S. Aron, Paula Gazder, H. Hughes Hawkins, Elyse E. Lower, Connie Seeskin, Rawia Yassin, Per-Olof Hassel...> ;Surgery. 2000 Oct 1
• 9 citations
  Phase I clinical trial of concurrent paclitaxel, carboplatin, and external beam chest irradiation with glutamine in patients with locally advanced non-small cell lung ...
  Abdul Rahman Jazieh, Ahmer Younas, M. M. Safa, Kevin P. Redmond, Ralph Buncher, John A. Howington> ;Cancer Investigation. 2007 Aug 1
• 6 citations
  Recurrent hypoglycemia associated with poorly differentiated carcinoma of the liver
  Muslim Atiq, M. M. Safa> ;American Journal of Clinical Oncology. 2007 Apr 1
• Join now to see all